Open AccessPercutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives
Author(s) -
Bart W. Driesen,
Evangeline G Warmerdam,
Gertjan T. Sieswerda,
Folkert J. Meijboom,
Mirella Molenschot,
Pieter A. Doevendans,
Gregor Krings,
Arie P.J. van Dijk,
Michiel Voskuil
Publication year - 2019
Publication title -
current cardiology reviews
Language(s) - English
Resource type - Journals
eISSN - 1875-6557
pISSN - 1573-403X
DOI - 10.2174/1573403x15666181224113855
Subject(s) - medicine , pulmonary valve , percutaneous , ventricular outflow tract , cardiology , ventricle , pulmonary valve insufficiency , pulmonary disease , heart disease , intensive care medicine , pulmonary regurgitation , tetralogy of fallot
Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.